FIBRYGA

Product Overview

About FIBRYGA

FIBRYGA is a medication containing FIBRINOGEN (HUMAN) as its active ingredient. It is used to treat bleeding disorders, including hemophilia A and von Willebrand disease, by providing a source of fibrinogen for the body to form blood clots.

Key Benefits & Uses

• Treatment of bleeding disorders, including hemophilia A and von Willebrand disease
• Management of bleeding complications in patients with fibrinogen deficiency
• Support for patients undergoing surgery or other procedures that may lead to bleeding

Active Ingredient & Action

FIBRINOGEN (HUMAN) is a protein that plays a crucial role in blood clotting. When administered as FIBRYGA, it helps to restore normal blood clotting function in patients with fibrinogen deficiency or dysfunction. The fibrinogen in FIBRYGA is derived from human plasma and is used to treat bleeding episodes and prevent bleeding complications.

Important Notes

FIBRYGA should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of adverse reactions. Patients with a history of allergic reactions to human plasma-derived products should not use FIBRYGA. Additionally, FIBRYGA may interact with other medications, so it is crucial to inform your healthcare provider of all medications you are taking before starting treatment.